Corbus Pharmaceuticals Holdings Inc
CRBP
Market Cap$490.73M
Close$
$-1.61
103.6% downside
Current Fair Value
103.6% downsideOvervalued by 103.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $490.73 Million |
|---|---|
| Enterprise Value | $412.58 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-0.37 |
| Beta | 0.52 |
| Outstanding Shares | 10,686,693 |
| Avg 30 Day Volume | 220,509 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -10.75 |
|---|---|
| PEG | -56.16 |
| Price to Sales | - |
| Price to Book Ratio | 7.5 |
| Enterprise Value to Revenue | 467.94 |
| Enterprise Value to EBIT | -7.37 |
| Enterprise Value to Net Income | -10 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.28 |
Revenue Sources
No data
ESG Score
No data
About Corbus Pharmaceuticals Holdings Inc
CEO: Yuval Cohen